Jean-Marc Extra

Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Flora Iovino et al. · Clinical Cancer Research · 2009 · 735 citations · Full text

Medicine, Cancer Biology, Oncology +17

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Incidence and Prognostic Significance of Complete Axillary Downstaging After Primary Chemotherapy in Breast Cancer Patients With T1 to T3 Tumors and Cytologically Proven Axillary Metastatic Lymph Nodes

Roman Rouzier, Jean-Marc Extra, Jerzy Klijanienko et al. · Journal of Clinical Oncology · 2002 · 311 citations

Medicine, Oncology, Pathology +17

Trastuzumab for Patients With Axillary-Node–Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial

M. Spielmann, Henri Roché, T. Delozier et al. · Journal of Clinical Oncology · 2009 · 299 citations

Medicine, Oncology, Pharmacotherapy +17

A gene expression signature identifies two prognostic subgroups of basal breast cancer

Renaud Sabatier, Pascal Finetti, Nathalie Cervera et al. · Breast Cancer Research and Treatment · 2010 · 289 citations

Life Sciences, Molecular Biology, Oncology +16